CIM LLC’s BioSpecifics Technologies Corp. BSTC Stock Holding History

CIM LLC’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,680	Closed	-$237K	–	171
2020 Q3	$237K	Buy	+2,680	New	+$165K	0.05%	129

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIM LLC's BSTC Position: Q4 2020 in Review

CIM LLC sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 2,680 shares — an estimated $237K sold.

CIM LLC first reported a position in BSTC in Q3 2020 and held it in 1 quarter. The position peaked at $237K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

CIM LLC reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
CIM LLC sold 2,680 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $237K.
CIM LLC first reported a position in BioSpecifics Technologies Corp. in Q3 2020 and held it in 1 quarter.
CIM LLC's BioSpecifics Technologies Corp. position peaked at $237K in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on CIM LLC's 13F filing for Q4 2020, filed 8 Feb 2021.